Steatotic Liver Disease of Mixed Origin (MetALD)

Explore clinical trials studying Steatotic Liver Disease of Mixed Origin (MetALD). Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Steatotic Liver Disease of Mixed Origin (MetALD) trial results

Not yet recruiting

NCT06907563

Conditions: ALD - Alcoholic Liver Disease, Alcohol-Induced Disorders, Alcohol-Related Disorders, +8 more
Locations: Hôpital de la Pitié Salpêtrière Paris, France

University Medical Center Saarland, Department of Internal Medicine II Homburg, Saarland, Germany

Division of Gastroenterology, Department of Medical Sciences, University of Turin Turin, Italy

Translational & Clinical Research Institute Faculty of Medical Sciences Newcastle upon Tyne, United Kingdom

Enrolling by invitation

NCT07613827

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +9 more
Locations: Shengjing Hospital of China Medical University Shenyang, Liaoning, China

Enrolling by invitation

NCT06514300

Conditions: Alcohol-related Liver Disease, Liver Histology, Magnetic Resonance Imaging, +5 more
Locations: Cliniques universitaires Saint-Luc Brussels, Belgium

Completed

NCT06924281

Conditions: Steatotic Liver Disease of Mixed Origin (MetALD)
Locations: Clinica Esperanza Hope Clinic Providence, Rhode Island, United States